Funded Biotechnology Startups in Canada
Among 50 recently funded Canadian biotechnology companies in the listing, the largest disclosed round is Xenon Pharmaceuticals’ $551M on 2026-03-10.
Among 50 recently funded Canadian biotechnology companies in the listing, the largest disclosed round is Xenon Pharmaceuticals’ $551M on 2026-03-10. That amount dwarfs the rest: the next-highest disclosed rounds are Helus Pharma at $50M (2026-06-24) and NervGen Pharma at $60M (2026-05-21), while many other disclosed rounds sit in the hundreds of thousands to low single-digit millions (e.g., Hemostemix at $260K on 2026-06-17; Telo Genomics at $860K on 2026-01-19).
The rounds cluster heavily by geography and timing. Vancouver, British Columbia and Toronto, Ontario each recur multiple times across the list (e.g., Aspect Biosystems $57M and enGene $18M in Vancouver; Medicus Pharma $16M and Medicenna Therapeutics $4M in Toronto), and most entries fall within a tight window from 2026-06-26 back to 2025-10-28. Stage/round labeling skews toward “Series Unknown” (43 of 50 rows), with “undisclosed” amounts appearing on 6 rows (e.g., Kintra on 2026-06-12; Entos Pharmaceuticals on 2026-01-06), making disclosed-size comparisons most reliable where amounts are present.
Most recent rounds
50 of 191141 more funded startups
This page shows the 50 most recent rounds (back to Oct 2025). The full 191-company history for this listing is available on a paid plan.
Unlock all 191 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
How does the largest disclosed Canadian biotech round compare to other disclosed rounds in this list?
Xenon Pharmaceuticals’ $551M (2026-03-10) is the only disclosed round over $100M. The next-largest disclosed rounds are NervGen Pharma’s $60M (2026-05-21) and Helus Pharma’s $50M (2026-06-24), with many other disclosed entries in the sub-$1M to low–single-digit millions (e.g., Hemostemix $260K on 2026-06-17; Telo Genomics $860K on 2026-01-19).
Are there city clusters—are Toronto or Vancouver over-represented?
Toronto shows up repeatedly (e.g., Medicenna Therapeutics $4M on 2026-06-26; Medicus Pharma $16M on 2026-05-28; Ontario Genomics $5M on 2026-05-08; Theralase Technologies $3M on 2026-05-05). Vancouver also recurs across multiple funding dates (e.g., NervGen Pharma $60M on 2026-05-21; Aspect Biosystems $57M on 2026-04-02; Applied Biological Materials $370K on 2026-04-17), suggesting both cities concentrate activity in this snapshot.
Which entries fall closest to the most recent round date shown?
The most recent entry is Medicenna Therapeutics on 2026-06-26 ($4M). In the following weeks of the listing window, several rounds cluster in late June 2026, including Helus Pharma on 2026-06-24 ($50M), Helostemix on 2026-06-17 ($260K), Avicanna on 2026-06-12 ($430K), and multiple $370K rounds (Esphera SynBio and Stoked Bio and Synmedix on 2026-05-11).
What stage/label pattern dominates the rounds—how much is “Series Unknown” vs specific stages?
“Series Unknown” appears in 43 of 50 rows, including large and small rounds such as Xenon Pharmaceuticals $551M (2026-03-10) and Block Biosciences $70K (2026-03-05). Explicit stage labels are comparatively rare: Seed appears on Kintra (undisclosed, 2026-06-12), Esphera SynBio ($370K, 2026-05-11), and Synmedix ($370K, 2026-05-11), Pre-Seed appears on Tydra Laboratories ($1M, 2026-04-14), and Series A appears on Morphocell Technologies ($10M, 2025-12-01).
Are there outliers in disclosed amount that warrant separate attention beyond the largest round?
Besides Xenon Pharmaceuticals’ $551M (2026-03-10), several mid-to-large disclosed rounds stand out against the many sub-$1M figures—examples include Alpha Compute Corp.’s $319M on 2026-04-22, and then $190K–$860K ranges for entries like AGADA Biosciences $420K (2026-03-03) and Telo Genomics $860K (2026-01-19). At the low end, the smallest disclosed amount is Block Biosciences at $70K (2026-03-05), while another set of entries lists “undisclosed” amounts (6 rows), limiting comparison for those specific dates.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.